UNSPSC 51411701: Pimefylline

This classification denotes a vasodilating agent and phosphodiesterase inhibitor with the molecular formula C15H18N6O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8680B5Y37A, chemically known as 3,7-dihydro-1,3-dimethyl-7-(2-((3-pyridinylmethyl)amino)ethyl)-1h-purine-2,6-dione but generally known as pimefylline, which bears US NIH Compound Identifier 65597. European Medicines Agency schedules Pimefylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09837MIG.

UNSPSC 51411701 Pimefylline, a Commodity code, covers pharmaceutical active ingredients and finished medications supplied to state and local public health agencies, emergency services, and managed healthcare programs. State and local governments buying under this code procure both branded and generic pharmaceuticals for emergency medical services (EMS), fire rescue departments, and state health insurance programs, typically through sealed competitive bids or cooperative purchasing agreements with established wholesaler networks. The code encompasses medications across multiple therapeutic classes—from emergency life-support drugs to multi-source generics and over-the-counter products—supplied under firm fixed-price contracts with strict expiration-date and shelf-life requirements, Cold Chain management where applicable, and compliance mandates including FDA registration, Good Manufacturing Practices certification, and Drug Supply Chain Security Act compliance. Issuing bodies include municipal fire and rescue departments, state health and human services commissions, and multistate cooperative purchasing alliances that aggregate demand across dozens of participating jurisdictions.

Recent activity centers on Florida and Minnesota, with Texas state agencies conducting preliminary market assessment. The City of Tampa's Purchasing Department issued a sealed bid (26P00188) in April 2026 for Advanced Life Support Medications—370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials for Tampa Fire Rescue, with responses due April 8, 2026 and an estimated contract value of $40,000. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP (S1070000015802) in January 2026 for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities including Oregon, with responses due March 26, 2026; awarded vendors deliver through three authorized wholesalers (Cencora, Cardinal Health 110 and 112, and Morris & Dickson) with contracts effective July 1, 2026. The Texas Health and Human Services Commission posted a Request for Information (HHS0017013) in April 2026 exploring direct-to-manufacturer prescription fulfillment strategies outside traditional pharmacy benefit manager and group purchasing organization channels, signaling potential expansion of procurement pathways beyond wholesale distribution.